Is Abbott Laboratories (ABT) Price Weakness Creating A Potential Opportunity Now? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
If you are wondering whether Abbott Laboratories' current share price around US$121.76 offers solid value, you are not alone. This article is here to break that question down in plain terms. The stock has seen a 3.3% decline over the last 7 days and a 3.9% decline over the last 30 days, while its 1 year return sits at 9.3%. This gives you a mix of recent weakness and longer term gains to think about. Recent attention on Abbott often centers on its broad healthcare product portfolio and how investors view large, diversified medical companies during changing market moods. These shifts in sentiment help explain why the share price can pull back in the short term even when the longer term story remains a focus for many shareholders. On our valuation checklist, Abbott Laboratories scores 3 out of 6 on undervaluation checks, giving it a valuation score of . Next we will walk through what different valuation approaches say about that number before finishing with a more complete way to
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythmsPR Newswire
- Abbott Laboratories: Q4 Earnings On The Horizon [Seeking Alpha]Seeking Alpha
- Abbott Laboratories (ABT) Positioned to Benefit as Healthcare Sector Enters Recovery Phase [Yahoo! Finance]Yahoo! Finance
- Rep. Julia Letlow Discloses Over 200 Stock Trades After Deadline As Ban Debate Grows In Congress [Forbes]Forbes
- Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $157.00 to $152.00. They now have a "buy" rating on the stock.MarketBeat
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- ABT's page on the SEC website